[Clinical use of thiopental in post-ischemic encephalopathy; preliminary report].
Twenty patients suffering from post-ischaemic encephalopathy were treated with high doses of barbiturates during the period immediately following resuscitation. The duration of cerebral ischaemia was assessed retrospectively. The degree of ischaemic damage was evaluated on the one hand by the pupillary signs seen 10 minutes after the reestablishment of the circulation and secondly by enzyme levels in the CSF. This barbiturate load was not associated with major complications and the excretion of barbiturate continued for several days. The clinical signs seen 12 hours after ischaemia and continuous observation of the tracing of the cerebral function monitor made it possible to give an early favourable prognosis from a neurological standpoint. In all the patients (apart from one) in whom there was total cerebral ischaemia for less than 10 minutes, neurological recovery was complete.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000134:cerebrospinal fluid; D002545:Brain Ischemia / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006323:Heart Arrest / Q000150:complications; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000134:cerebrospinal fluid; D007773:Lactates / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D011773:Pyruvates / Q000134:cerebrospinal fluid; D012025:Reflex, Pupillary; D012151:Resuscitation; D013874:Thiopental / Q000627:therapeutic use*; D013997:Time Factors
D007773:Lactates; D011773:Pyruvates; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D013874:Thiopental
Utilisation clinique du thiopental dans l'encéphalopathie post-ischémique; rapport préliminaire.